Sheng Hu
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy Study of Virus Activated Killer Immune Cells (VAK) for Malignant Pleural and Peritoneal Effusion (NCT05565014) | Sheng Hu | 2020-07-24 |
Track Sheng Hu automatically
Every clearance here is in the API, with alerts when new ones post.